Bayer settles whistleblower kickback allegations for $40m

German pharmaceutical firm Bayer has agreed to pay $40m in a settlement with the US Department of Justice (DoJ) to resolve allegations of kickbacks paid to physicians to use its medicines.

Two cases were pursued by whistleblower Laurie Simpson from Bayer’s marketing team. She is expected to recei...


Want to read this article?

Register for ultimate access to this article and ALL our premium content

ULTIMATE ACCESS PROVIDES YOU WITH

  • Unrestricted access to Commercial Risk, Commercial Risk Europe and Global Risk Manager news, exclusive expert analysis and opinion
  • Breaking news, daily and/or weekly Commercial Risk Europe newsletters and regular digital publications
  • Breaking news, weekly and monthly Global Risk Manager newsletters and quarterly digital Journal
  • European and global surveys, rankings and special reports
  • National European local language newsletters
  • Preferential access to webinars and virtual and physical conferences

If you are already a registered user or subscriber you can LOGIN below for ultimate access:

Back to top button